FAYETTEVILLE, GA, UNITED STATES, February 15, 2026 /EINPresswire.com/ -- Age-related cataract is often viewed as an ...

Plasma brain-derived tau is emerging as a sensitive biomarker for Alzheimer’s disease and acute neurological disorders, ...

Immunoprecipitation-enhanced blood-based biomarkers are improving early diagnosis of Alzheimer’s disease by enabling more ...

Coherus BioSciences shows underwhelming LOQTORZI sales and reliance on upcoming pipeline catalysts. Read why CHRS stock is ...

The Alzheimer’s ‘clock’ could make it easier to treat the disease early, before memory problems appear. A simple blood test might one day serve as a molecular ‘clock’ that predicts not only whether ...

Globally, millions of people are affected by Alzheimer's disease, with around 120,000 individuals in Norway alone. Witnessing a loved one gradually decline because of this devastating condition can be ...

Cancer remains a formidable global health challenge, characterized by the uncontrolled growth and spread of abnormal cells, leading to millions of deaths annually. Traditional treatment modalities ...

The global market for Precision Medicine Research and Development Platform was valued at USD 84730 Million in the year 2024 and is projected to reach a revised size of USD 120230 Million by 2031, ...

ZENTALIS® and its associated logo are trademarks of Zentalis and/or its affiliates. All website addresses and other links in this press release are for information only and are not intended to be an ...

Upon exercise of the option and completion of the acquisition, AlphaTON would be entitled to an upfront cash payment at closing, equity consideration representing 10% of the fully diluted equity of ...

Neflamapimod endorsement based on targeted mechanism of action, demonstrated clinical activity in neurodegenerative diseases, and encouraging ...

Extensive peer-reviewed research has identified biologically active nutrients and biochemical intermediates that play ...